RxDoctor Payments Data

Ryan McBride, DPM

Foot & Ankle Surgery · Cedar Rapids, IANPI 1700060944

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,694 of the $3,767 with a category attached, or 71.5%. Stryker accounts for 61.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $1,723 and has fallen 82.0% since, to $311 in 2025.

$3,767in general payments, 2019–2025

Across 112 payments — averaging $33.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Organogenesis Inc.$437
  • Johnson & Johnson$238
  • Convatec Inc.$226
  • Zimmer Biomet$218
  • Kerecis Limited$76
  • plus $267 from 12 others

What the payments were for

  • Travel & lodging$1,06928%
  • Food & beverage$2,69472%
  • Education$40%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,767 in reported general payments places this provider in the 60th percentile of 112 foot & ankle surgery providers in Iowa.

See all foot & ankle surgery providers in Iowa

Medicare billing

Part B allowed, 2024
$227,011
Medicare patients
429
Services billed
2,687

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin70$748
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen71$698
Allopurinol101$324
Cephalexin30$287
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$110
Tramadol Hcl19$79
Doxycycline Monohydrate12$56
Meloxicam22$42

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Cedar Rapids

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →